Open AccessHAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS?
Author(s) -
Е. П. Панченко
Publication year - 2017
Publication title -
aterotromboz
Language(s) - English
Resource type - Journals
eISSN - 2658-5952
pISSN - 2307-1109
DOI - 10.21518/2307-1109-2017-2-32-42
Subject(s) - clopidogrel , medicine , disease , mortality rate , antiplatelet drug , drug , cause of death , cardiology , aspirin , intensive care medicine , pharmacology